Ergot alkaloids as dopamine agonists: comparison in two rodent models

Area of Science:

• Neuropharmacology
• Behavioral Neuroscience

Background:

• Ergot alkaloids are a class of compounds with diverse pharmacological effects.
• Dopamine (DA) pathways are crucial in regulating motor control and sensory processing.
• Audiogenic seizures and circling behavior are established models for studying neurological function and drug efficacy.

Purpose of the Study:

• To investigate the potential dopamine agonist activity of ergot alkaloids.
• To evaluate the efficacy of ergot alkaloids and known dopamine agonists in animal models of seizures and motor control.

Main Methods:

• Testing ergot alkaloids and dopamine agonists (apomorphine, piribedil) in DBA/2 mice for protection against audiogenic seizures.
• Assessing the induction of circling behavior in mice with unilateral nigrostriatal pathway destruction.
• Administering the neuroleptic agent haloperidol to block observed effects.

Main Results:

• Ergot alkaloids demonstrated protective effects against audiogenic seizures, with varying potencies.
• Apomorphine, ergocornine, bromocryptine, and ergometrine induced circling behavior, indicating dopamine agonism.
• LSD showed weak circling behavior, while methysergide was ineffective.
• Haloperidol blocked the effects of both dopamine agonists and ergot alkaloids in both models.

Conclusions:

• Certain ergot alkaloids exhibit dopamine agonist properties.
• These findings support the investigation of ergot alkaloids for neurological conditions involving dopamine pathways.
• The study highlights the utility of audiogenic seizure and circling behavior models in neuropharmacological research.